Search Results - "Di Mauro, Gabriella"
-
1
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
Published in International immunopharmacology (01-07-2020)“…The new coronavirus outbreak is an ongoing pandemic that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus…”
Get full text
Journal Article -
2
The Safety Profile of General and Local Anaesthetic Agents: Data Collected during 20 Years of Spontaneous Reporting Activities in the Campania Region (Southern Italy)
Published in Pharmaceuticals (Basel, Switzerland) (03-12-2021)“…General and local anaesthetics are widely used during surgery. These drugs have peculiar safety profiles, being commonly associated with mild and reversible…”
Get full text
Journal Article -
3
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature
Published in Journal of infection and public health (01-03-2023)“…The ESCMID-EUCIC guideline on decolonization of multidrug-resistant Gram-negative bacteria carriers does not recommend routine decolonization and highlights…”
Get full text
Journal Article -
4
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review
Published in Journal of pharmacology & pharmacotherapeutics (01-07-2018)“…The aim of this study was to investigate the scientific contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions…”
Get full text
Journal Article -
5
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review
Published in Therapeutics and clinical risk management (01-01-2017)“…The use of contrast media in Italy has exponentially increased in the past 3 decades. However, it is unknown whether there has been an increase in clinical…”
Get full text
Journal Article -
6
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
Published in Frontiers in immunology (03-10-2022)“…IntroductionAlthough the European Medicines Agency (EMA) encourage coronavirus disease 2019 (COVID-19) vaccination in pregnant women, the scientific evidence…”
Get full text
Journal Article -
7
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
Published in Frontiers in pharmacology (13-02-2019)“…Despite several innovative medicines gaining worldwide approval in recent years, there are still therapeutic areas for which unsatisfied therapeutic needs…”
Get full text
Journal Article -
8
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
Published in Frontiers in pharmacology (20-04-2021)“…The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular circulating hormonal system, it is now accepted as a local tissue system…”
Get full text
Journal Article -
9
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma ® ) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
Published in Pharmaceuticals (Basel, Switzerland) (01-03-2024)“…The recent introduction of the innovative therapy, onasemnogene abeparvovec (Zolgensma ), has revolutionized the spinal muscular atrophy (SMA) therapeutic…”
Get full text
Journal Article -
10
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
Published in Frontiers in pediatrics (22-07-2022)“…BackgroundBlinatumomab is a bispecific CD19-directed CD3 T-cell engager that has proven efficacy in children with relapsed or refractory B-cell acute…”
Get full text
Journal Article -
11
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
Published in Pharmaceuticals (Basel, Switzerland) (27-05-2022)“…Few data have been published on the effects of impaired glucose metabolism induced by COVID-19 vaccines. We decided to perform a study to describe Individual…”
Get full text
Journal Article -
12
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
Published in Pharmaceuticals (Basel, Switzerland) (25-02-2022)“…Dapagliflozin was associated with an increased risk of diabetic ketoacidosis that has led to the European withdrawal of the authorization for the type 1…”
Get full text
Journal Article -
13
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
Published in Frontiers in pharmacology (06-11-2023)“…Background: The risk of falls and bone fractures with sodium-glucose co-transporter-2 (SGLT2) inhibitors has been characterized by conflicting evidence…”
Get full text
Journal Article -
14
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
Published in Frontiers in oncology (15-03-2022)“…Immune checkpoint inhibitors (ICIs) are widely used improving clinical outcomes in many cancer patients. However, they can induce serious consequences, like…”
Get full text
Journal Article -
15
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
Published in Frontiers in pharmacology (09-06-2020)“…The introduction of immune checkpoint inhibitors (ICIs) in clinical practice has brought significant benefits for patients. Seven ICIs are available in Europe:…”
Get full text
Journal Article -
16
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System
Published in Pharmaceuticals (Basel, Switzerland) (01-11-2023)“…Botulinum toxin is a protein deriving from the bacteria Clostridium botulinum and it is widely used for the treatment of a variety of muscle hyperactivity…”
Get full text
Journal Article -
17
Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
Published in Frontiers in pharmacology (26-05-2017)“…This study aims to investigate preventability criteria of adverse drug reactions (ADRs) involving non-steroidal anti-inflammatory drugs (NSAIDs) by analyzing…”
Get full text
Journal Article -
18
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
Published in Frontiers in pharmacology (06-09-2017)“…To investigate the occurrence of adverse events (AEs) in naïve patients receiving biotech drugs. A prospective observational study. Onco-hematology,…”
Get full text
Journal Article -
19
Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
Published in Frontiers in pharmacology (12-06-2018)“…The aim of this study is to investigate if following the implementation of the Regulation EU/1235/2010 and the Directive 2010/84/EU there was an increase of…”
Get full text
Journal Article -
20
COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre
Published in International journal of cardiology congenital heart disease (01-12-2021)“…real-world data on COVID-19 vaccine safety, immunogenicity and acceptance in adults with congenital heart disease (ACHD) are lacking. ACHD patients who were…”
Get full text
Journal Article